Abiopharma

New Form 4 - Climb Bio, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106563 Size: 4 KB

Longeveron - Longeveron Announces Closing Of Up To $17.5 Million Public Offering

New Form 10-Q - Arcturus Therapeutics Holdings Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106560 Size: 6 MB

Longeveron Announces Closing Of Up To $17.5 Million Public Offering

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

New Form 10-Q - Tempest Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106558 Size: 7 MB

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

New Form 8-K - Gevo, Inc. Filed: 2025-08-11 AccNo: 0001392380-25-000023 Size: 743 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - Zai Lab Ltd Filed: 2025-08-11 AccNo: 0001959173-25-005092 Size: 9 KB

New Form NT 10-Q - Esperion Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001628280-25-039562 Size: 34 KB

New Form 10-Q - Assertio Holdings, Inc. Filed: 2025-08-11 AccNo: 0001808665-25-000026 Size: 6 MB

New Form 10-Q - Sana Biotechnology, Inc. Filed: 2025-08-11 AccNo: 0001770121-25-000010 Size: 11 MB

Myomo Reports Second Quarter 2025 Financial and Operating Results

New Form 8-K - Insight Molecular Diagnostics Inc. Filed: 2025-08-11 AccNo: 0001641172-25-022974 Size: 702 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Serina Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001708599-25-000091 Size: 352 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits